PubMed · 14874747
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R J COOK, A L GROPPER. A new galvanometer source light.. https://pubmed.ncbi.nlm.nih.gov/14874747/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Personalized medicine: is it hype or revolution? In any case, there is not only real demand for it, but it also has a history. As it is, the personal aspects of health care have been partly neglected in the current era of evidence-based, scientific medicine. We now know that a 'one fits all' type of treatment has its limits. Medicine needs to be (re-)personalized. The time is right: the post-genomic era provides the necessary molecular tools, but does it provide for the risks involved? Privacy, protection of minorities, and prevention of discrimination are at stake. Regulations are required. The health-care process needs redesigning to render personalized medicine effective. Information and communication management is challenged to handle the wealth of personal information and link to global medical knowledge. But the goal is magnificent: personal health planning, early diagnosis, the right drug for the right patient, and predictable side effects.
Neonatal and paediatric intensive care has improved the prognosis for seriously sick infants and children. This has happened because of a pragmatic approach focused on stabilisation of vital functions and immense technological advances in diagnostic and therapeutic procedures. However, the belief that more medical care must inevitably lead to improved health is increasingly being questioned. This issue is especially relevant in developing countries where the introduction of highly specialised paediatric intensive care may not lead to an overall fall in child mortality. Even in developed countries, the complexity and availability of therapeutics and invasive procedures may put seriously ill children at additional risk. In both developing and industrialised countries the use of safe and simple procedures for appropriate periods, particular attention to drug prescription patterns and selection of appropriate aims and modes of therapy, including non-invasive methods, may minimise the risks of paediatric intensive care.
General Electric Co. and other technology vendors see a golden opportunity in cash-strapped hospital clients. By also offering financing and consulting services, they're helping their providers stay in the game long enough to pay them back for their high-tech goods, and come back for more. GE's Rick Wolfert says, "We have reason to believe we either are or soon will be the leading provider."